Physiol. Genomics 35: 55-64, 2008.
First published July 8, 2008; doi:10.1152/physiolgenomics.90247.2008
1094-8341/08 $8.00
Received 12 May 2008;
accepted in final form 7 July 2008.
Physiological Genomics 35:55-64 (2008)
1094-8341/08 $8.00 © 2008 American Physiological Society
Prioritization of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes
Nicki Tiffin1,
Ikechi Okpechi2,
Carolina Perez-Iratxeta3,
Miguel A. Andrade-Navarro3,4 and
Rajkumar Ramesar1
1 Division of Human Genetics, MRC Human Genetics Research Unit, Institute for Infectious Diseases and Molecular Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
2 Nephrology Division and Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
3 Ontario Genomics Innovation Centre, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
4 Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
There is a rapid increase in the world-wide burden of disease attributed to metabolic syndrome, as defined by co-occurrence of an array of phenotypes including abdominal obesity, dysglycemia, hypertriglyceridemia, low levels of high density lipoprotein cholesterol, and hypertension. Familial studies clearly indicate a genetic component to the disease and many linkage studies have identified a large number of linked loci. No disease-causing genes, however, have been conclusively identified, most likely because this is a multigenic disease for which effects of many causative genes may be small and combined with environmental effects. To assist empirical identification of metabolic syndrome associated genes, we present here a novel computational approach to prioritize candidate genes. We have used linkage studies and the clinical and population-specific presentation of the disease to select a final candidate gene list of 19 most likely disease-causing genes. These are predominantly involved in chylomicron processing, transmembrane receptor activity, and signal transduction pathways. We propose here that information about the clinical presentation of a complex trait can be used to effectively inform computational prioritization of disease-causing genes for that trait.
candidate genes; complex disease
Copyright © 2008 by the American Physiological Society.